person

Christa D. H.

Country
Germany
Department
#2119

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 19 partner sites.

Specializations

Lipid Disorders & Cardiovascular Risk Reduction

The investigator concentrates on therapeutic strategies for atherosclerotic cardiovascular disease, hypercholesterolemia and elevated lipoprotein(a), emphasizing intensive LDL‑C lowering.

  • inclisiran
  • bempedoic acid comparison
  • Lp(a) targeted agents

Research advances novel lipid‑modifying regimens to mitigate residual cardiovascular risk.

Neuropathic and Chronic Pain Management

Work in this area addresses chronic neuropathic pain of diabetic, peripheral and central origin, as well as persistent chronic back pain.

  • AP707
  • multimodal neuropathic pain therapies
  • pain‑relief outcome measures

Efforts aim to improve functional recovery and patient comfort.

Heart Failure and Cardiovascular Outcome Trials

Focus includes symptomatic heart failure with reduced ejection fraction and prevention of major adverse cardiovascular events.

  • XXB750
  • AZD0780
  • NT‑proBNP reduction

Studies evaluate disease‑modifying effects on cardiac remodeling and event rates.

Metabolic Syndrome & Diabetes with Hypertension

Investigations target patients with type 2 diabetes, co‑existing hypertension and established cardiovascular disease.

  • vicadrostat + empagliflozin combination
  • integrated metabolic‑cardiac risk reduction
  • blood pressure and glycemic control endpoints

The approach seeks synergistic benefits across metabolic and vascular pathways.

Mental Health and Gastrointestinal Disorders

Research spans major depressive disorder of mild to moderate severity, irritable bowel syndrome with diarrhoea predominance, and acute pharyngitis.

  • Silexan
  • Symbioflor®2
  • benzydamine lozenges

These projects explore novel agents for mood regulation, gut microbiome modulation and symptomatic relief of upper‑airway infections.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.